News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
The alliance has also deepened its ongoing partnership with ELIXIR, while continuing to roll out new tools and standards for genomic data discovery, analysis, and interpretation.
The Philips platform will support oncology testing workflows and helped with the launch of Illumina TruSight Tumor 170 NGS testing at the Florida institute.
The firms will use AbCellera's antibody discovery platform, which combines a variety of technologies including next-generation sequencing and bioinformatics.
The firm has developed a microbiome analytics platform for supply chain management that combines next-generation sequencing and artificial intelligence.
IBM and the Broad Institute will codevelop algorithms to apply artificial intelligence to predict cardiovascular risk from genomic and clinical data.
